Jerusalem based Oramed to dual list on TASE
Jerusalem based Oramed Pharmaceuticals Inc. (Nasdaq:ORMP), which develops orally administered drugs as a substitute for injections, has announced that the Israel Securities Authority has authorized the dual listing of its shares…
Continue Reading
Jerusalem based Oramed to dual list on TASE